Cardiac β2 adrenergic receptor deletion drives calmodulin kinase II upregulation to induce connective tissue growth factor in cardiac fibrosis and diastolic dysfunction
Function · 2025
DOI: 10.1093/function/zqaf036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Function, 2025. Verfasst von Chaoqun Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. Hauptthemen laut MEDLINE: Connective Tissue Growth Factor, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Receptors, Adrenergic, beta-2, Myocytes, Cardiac. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, American Heart Association.
Abstract (Originalsprache)
Abnormalities of Ca2+ signaling in the heart lead to common cardiac remodeling in the pathogenesis of cardiovascular disorders. The activation of calmodulin-dependent protein kinase II (CaMKII) is regulated by elevated intracellular Ca2+ level in cardiomyocytes, driving the progression of myocardial dysfunction. In this study, using models of β2 adrenergic receptor (β2AR) deficiency in cardiomyocytes (β2AR-CKO), we observed an increased phosphorylation of CaMKII and upregulation of gene expression and protein level of the fibrotic marker connective tissue growth factor (CTGF) in the myocytes. In vivo treatment with the CaMKII inhibitor KN93 attenuated the upregulation of CTGF protein expression in β2AR-CKO hearts. Enhanced L-type calcium channel (LTCC) current was observed in β2AR-CKO cardiomyocytes following adrenergic stimulation, indicating a disruption of Ca2+ signaling. Treatment with the LTCC blocker nifedipine attenuated CaMKII activity and the expression of CTGF in β2AR-CKO hearts, confirming the upstream role of abnormal LTCC-Ca2+ signaling. Additionally, 8-month-old β2AR-CKO mice exhibited cardiac fibrosis and diastolic dysfunction. One month of in vivo nifedipine treatment improved both cardiac dysfunction and fibrosis in β2AR-CKO mice. These findings highlight the critical role of cardiomyocyte β2AR in maintaining LTCC-Ca2+ homeostasis. Loss of β2AR amplifies the Ca2+-CaMKII axis, promoting fibrosis and cardiomyopathy in aging hearts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA.
- Department of Pharmaceutical Toxicology, China Medical University, Shenyang 110122, China.
- Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX 77204, USA.
- VA Northern California Health Care System, Mather, CA 95655, USA.
ORCID-Profile: Mingfu Wu, Yang K Xiang
Förderung
- NHLBI NIH HHS
- NIH HHS
- American Heart Association
- VA Merit
- BLRD VA
- National Institutes of Health
Zitieren
APA
Zhu, C., Zhao, M., Zhao, L., Wu, M., & Xiang, Y. K. (2025). Cardiac β2 adrenergic receptor deletion drives calmodulin kinase II upregulation to induce connective tissue growth factor in cardiac fibrosis and diastolic dysfunction. Function. https://doi.org/10.1093/function/zqaf036
Vancouver
Zhu C, Zhao M, Zhao L, Wu M, Xiang YK. Cardiac β2 adrenergic receptor deletion drives calmodulin kinase II upregulation to induce connective tissue growth factor in cardiac fibrosis and diastolic dysfunction. Function. 2025. doi:10.1093/function/zqaf036
BibTeX
@article{Zhu2025,
author = {Zhu, Chaoqun and Zhao, Meimi and Zhao, Luqi and Wu, Mingfu and Xiang, Yang K},
title = {Cardiac β2 adrenergic receptor deletion drives calmodulin kinase II upregulation to induce connective tissue growth factor in cardiac fibrosis and diastolic dysfunction},
journal = {Function},
year = {2025},
doi = {10.1093/function/zqaf036}
}
EUVIMED